Riluzol: un nuevo agente para la esclerosis lateral amiotrófica

Autores
Categoría Resumen estructurado de revisiones sistemáticas
RevistaDatabase of Abstracts of Reviews of Effects (DARE)
Año 1998
Cargando información sobre las referencias

CRD COMMENTARY:

The summary mentions only 2 large scale trials, and it is unclear whether there are other smaller trials which have not been included in the review. Also, the search is limited and searches of other databases (e.g. EMBASE) would have uncovered other relevant studies. There are few methodological details relating to the review itself. It is therefore unclear whether the results of the review are robust. As there are only 2 large trials included, the conclusions of the review may be susceptible to publication bias.
Epistemonikos ID: 60349eee0c6bfbb1d00a271522b213c5777c3785
First added on: Feb 05, 2012